• Lucid Diagnostics (NASDAQ:LUCD) Earns "Buy" Rating from Canaccord Genuity Group

    来源: Buzz FX / 14 11月 2024 12:31:18   America/New_York


    Lucid Diagnostics (NASDAQ:LUCD) Earns "Buy" Rating from Canaccord Genuity Group Written by MarketBeat November 14, 2024 Share Link copied to clipboard. Lucid Diagnostics ( NASDAQ:LUCD - Get Free Report ) 's stock had its "buy" rating reaffi
    Read more...
分享